Ordinary Rebalance | Solactive Transatlantic Healthcare Equity Index | Effective Date 10th October 2022
In the ordinary rebalancing the following index composition will be implemented effective open 10.10.2022:
ABBOTT LABORATORIES |
ABBVIE INC |
ALCON INC |
AMGEN INC |
BAXTER INTL. |
BAYER AG |
BECTON DICKINSON AND CO |
BIOMERIEUX |
BOSTON SCIENTIFIC CORP |
BRISTOL-MYERS SQUIBB CO |
CENTENE |
CIGNA CORP |
ELEVANCE HEALTH INC |
ELI LILLY & CO |
ENSIGN GROUP INC |
ESSILORLUXOTTICA |
FRESENIUS SE & CO KGAA |
GILEAD SCIENCES INC |
GSK PLC |
HOLOGIC INC |
HUMANA INC |
INCYTE CORP |
INTEGRA LIFESCIENCES HOLDING |
IRONWOOD PHARMACEUTICALS INC |
JAZZ PHARMACEUTICALS PLC |
JOHNSON & JOHNSON |
LABORATORY CRP OF AMER HLDGS |
LHC GROUP INC |
MEDTRONIC PLC |
MERCK & CO. INC. |
MERCK KGAA |
MOLINA HEALTHCARE INC |
NOVARTIS AG |
NOVO NORDISK A/S |
ORGANON & CO |
ORION OYJ CLASS B |
PERRIGO CO PLC |
PFIZER INC |
PRESTIGE CONSUMER HEALTHCARE INC |
QIAGEN NV |
QUEST DIAGNOSTICS INC |
RESMED INC |
ROCHE HOLDING AG |
ROYALTY PHARMA PLC- CL A |
SANOFI SA |
STRYKER CORP |
UCB SA |
UNITEDHEALTH GROUP INC |
ZIMMER BIOMET HOLDINGS INC |
ZOETIS INC |